Organon & Co | الأصول



Assets تغيير تاريخ
Adcock Ingram Holdings ZAR 8.74B 388.13M 2024-12
Bristol-Myers Squibb USD 94.68B 2.25B 2025-06
Celltrion KRW 20.96T 96.41B 2025-03
Cspc Pharmaceutical CNY 44.39B 3.51B 2024-12
Dianthus Therapeutics USD 326.08M 47.93M 2025-06
Divis Laboratories Ltd 169.32B 13.46B 2025-03
Gilead Sciences USD 55.72B 713M 2025-06
Glaxosmithkline GBP 59.26B 205M 2025-06
Kangmei Pharma CNY 13.64B 69.1M 2025-06
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 869.6M 37.58M 2025-06
Malin Corporation EUR 198.5M 70.1M 2024-12
Medical Developments International AUD 65.33M 6.17M 2024-12
Merck USD 117.52B 2.4B 2025-06
Neuren Pharmaceuticals AUD 409.71M 181.55M 2024-12
Novartis USD 104.4B 2.15B 2025-06
Organigram Holdings CAD 564.62M 85.41M 2025-06
Organon & Co USD 13.5B 344M 2025-06
Pharma Mar EUR 348.25M 14.75M 2025-06
Qiagen NV USD 5.82B 278.39M 2025-06
Sartorius EUR 10.03B 85.1M 2025-06
Sino Biopharmaceutical CNY 65.41B 1.3B 2024-12
Tilray USD 4.19B 70.11M 2024-11


Organon & Co الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Sep 2025.